A protein called NF-kB c-Rel has been found to intensify the symptoms of psoriasis, offering a potential new target for ...

Medicaid is a needs-based program, but the misconception that it is a program solely for poor people has made it a target for ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...

Blue Cross Blue Shield of Michigan said it is evaluating any potential updates to the coverage process for Darzalex Faspro ...

But major cuts to federal for Medicaid are a likely outcome of the $1.5-$2 trillion in spending cuts over the next 10 years ...

At what was supposed to be a hearing to discuss PBM reform, some in Congress veered off into discussions about Medicaid and ...

Three Washington, D.C., healthcare policy experts and the former chief of staff of HHS dive into the healthcare politics and policies of the new administration: RFK Jr.’s confirmation hearings; the ...

This once-daily topical treatment is the latest phosphodiesterase-4 (PDE4) inhibitor designed for mild to moderate atopic ...

Researchers, physicians, families and affected patients view Duchenne muscular dystrophy (DMD) as a neuromuscular condition. Children are diagnosed during the first years of life because they have ...

The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.

The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...